Indiana House Bill 1184 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 9 2024 - 25% progression, died in committee
Action: 2024-01-09 - First reading: referred to Committee on Public Health
Pending: House Public Health Committee
Text: Latest bill text (Introduced) [PDF]

Breakthrough therapies. Establishes the breakthrough therapies research fund. Provides that a drug, biological product, or medical device that has been designated as a breakthrough therapy under federal law may be made available to a qualified patient and offered by a physician as a part of the patient's medical treatment. Specifies that a civil or criminal cause of action is not created against a manufacturer or health care provider for any harm to a qualified patient resulting from use of an investigational drug, biological product, or device.

Breakthrough therapies.

Rep. Justin Moed [D]

Date	Chamber	Action
2024-01-09	House	First reading: referred to Committee on Public Health
2024-01-09	House	Authored by Representative Moed

Type	Source
Summary	https://iga.in.gov/legislative/2024/bills/house/1184/details
Text	https://iga.in.gov/pdf-documents/123/2024/house/bills/HB1184/HB1184.01.INTR.pdf
Supplement	https://iga.in.gov/pdf-documents/123/2024/house/bills/HB1184/fiscal-notes/HB1184.01.INTR.FN001.pdf